Company intelligence / Profile preview

Key Oncologics

Johannesburg, Gauteng, South Africa

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Key Oncologics is a specialized pharmaceutical company based in South Africa that focuses on the marketing and distribution of oncology and hematology products. The company partners with global biotechnology and pharmaceutical firms to bring innovative cancer treatments to the Southern African market. Their portfolio includes a range of chemotherapy agents, targeted therapies, and supportive care medications. Key Oncologics provides comprehensive medical support and education to healthcare professionals to ensure the optimal use of their specialized therapeutic offerings.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyBiologic
Industry: Drug Discovery Services

Partnerships

RocheAmgenPierre FabreKyowa KirinAccord Healthcare

Beyond the preview

Go deeper on Key Oncologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Key Oncologics.

Explore the full profile